Two are better than one on progression through MET mechanism for EGFR+ NSCLC patients

Transl Lung Cancer Res. 2018 Dec;7(Suppl 4):S334-S335. doi: 10.21037/tlcr.2018.12.01.

Authors

Waleed Kian¹, Laila C Roisman¹, Nir Peled¹

Affiliation

¹ The Legacy Heritage Oncology Center & Dr. Larry Norton Institute, Soroka Medical Center & Ben-Gurion University, Beer-Sheva, Israel.

No abstract available

Publication types

Editorial
Comment